The AMER1 Gene Osteopathia Striata with Cranial Sclerosis NGS Genetic DNA Test is a cutting-edge diagnostic tool designed to identify genetic mutations associated with osteopathy and cranial sclerosis. This test utilizes Next Generation Sequencing (NGS) technology to provide accurate and comprehensive insights into the genetic factors influencing these conditions. Understanding your genetic predisposition is crucial for early diagnosis and management of potential health issues.
Turnaround time for results is approximately 3 to 4 weeks. The test can be performed using blood, extracted DNA, or even a drop of blood on an FTA card. Before the test, it is essential to provide a clinical history and undergo a genetic counseling session to create a pedigree chart of family members affected by the AMER1 gene.